← 產業報告目錄
Clinical Trials Manufacturing and Supply Outsourcing Market Size, Share & Trends Analysis Report By Service Type (Manufacturing, Logistics & Distribution, Storage & Retention, Others), By Phase Type (Phase-I, Phase-II, Phase-III, Phase-IV), By End-User (Pharmaceutical Companies, Biotechnology Companies, Others), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-17頁數 179報告編號 INSIGHTACE-d87e2898e7
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 13.4 Bn, the global Clinical Trials Manufacturing and Supply Outsourcing Market is forecasted to advance to USD 22.4 Bn by 2034, demonstrating a CAGR of 7.3% during the 2025–2034 forecast window.
Clinical Trials Manufacturing and Supply Outsourcing covers a strategic technique utilized by pharmaceutical and biotechnology businesses to generate the investigational medications and supplies required f. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trials Manufacturing & Supply Outsourcing Market Snapshot
Chapter 4. Global Clinical Trials Manufacturing & Supply Outsourcing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Type Estimates & Trend Analysis
5.1. By Service Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service Type:
5.2.1. Manufacturing
5.2.2. Logistics & Distribution
5.2.3. Storage & Retention
5.2.4. Others
Chapter 6. Market Segmentation 2: By Phase Type Estimates & Trend Analysis
6.1. By Phase Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Phase Type:
6.2.1. Phase-I
6.2.2. Phase-II
6.2.3. Phase-III
6.2.4. Phase-IV
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
7.2.1. Pharmaceutical Companies
7.2.2. Biotechnology Companies
7.2.3. Others
Chapter 8. Clinical Trials Manufacturing & Supply Outsourcing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
8.1.2. North America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) estimates and forecasts By Phase Type, 2021-2034
8.1.3. North America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.1.4. North America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Service Type, 2021-2034
8.2.2. Europe Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Phase Type, 2021-2034
8.2.3. Europe Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By End User, 2021-2034
8.2.4. Europe Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Service Type, 2021-2034
8.3.2. Asia Pacific Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Phase Type, 2021-2034
8.3.3. Asia Pacific Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By End User, 2021-2034
8.3.4. Asia Pacific Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Service Type, (US$ Million) 2021-2034
8.4.2. Latin America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Phase Type, (US$ Million) 2021-2034
8.4.3. Latin America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.4.4. Latin America Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Service Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By Phase Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Clinical Trials Manufacturing & Supply Outsourcing Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Catalent
9.2.2. Parexel
9.2.3. Almac Group Limited
9.2.4. Patheon
9.2.5. Thermo Fischer Scientific
9.2.6. Klifo
9.2.7. Movianto
9.2.8. Eurofins Scientific
9.2.9. Clinigen
9.2.10. Spaulding Clinical
9.2.11. Singota
9.2.12. Symeres
9.2.13. Ardena
9.2.14. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們